Alerts will be sent to your verified email
Verify EmailSTAR
Strides Pharma Scien
|
Laxmi Organic Inds.
|
Wockhardt
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
260.0 . | n/a | n/a |
Number of ANDA's Approved By USFDA
|
235.0 . | n/a | n/a |
R&D as a % of Total Sales
|
2.24 % | n/a | 4.2 % |
Financials
|
|||
5 yr Average ROE
|
-1.06 % | 14.71 % | -2.51 % |
5yr average Equity Multiplier
|
2.7 | 2.0 | 2.4 |
5yr Average Asset Turnover Ratio
|
0.45 | 1.29 | 0.4 |
5yr Avg Net Profit Margin
|
0.77 % | 5.83 % | -2.24 % |
Price to Book
|
3.92 | 4.87 | 2.82 |
P/E
|
0.0 | 70.71 | 0.0 |
5yr Avg Cash Conversion Cycle
|
-89.35 Days | 8.54 Days | -159.51 Days |
Inventory Days
|
71.49 Days | 37.92 Days | 72.12 Days |
Days Receivable
|
73.25 Days | 80.83 Days | 73.25 Days |
Days Payable
|
261.28 Days | 113.09 Days | 241.3 Days |
5yr Average Interest Coverage Ratio
|
0.64 | 10.34 | -0.73 |
5yr Avg ROCE
|
6.23 % | 17.71 % | -1.75 % |
5yr Avg Operating Profit Margin
|
14.43 % | 10.53 % | 5.17 % |
5 yr average Debt to Equity
|
1.04 | 0.26 | 0.84 |
5yr CAGR Net Profit
|
n/a | 11.47 % | 23.51 % |
5yr Average Return on Assets
|
-0.26 % | 7.44 % | -1.05 % |
Shareholdings
|
|||
Promoter Holding
|
25.88 % | 69.72 % | 51.6 % |
Share Pledged by Promoters
|
72.7 % | 0.0 | 52.9 % |
Change in Promoter Holding (3 Yrs)
|
-3.79 % | -3.2 % | -20.52 % |
Change in Mutual Fund Holding (3 Yrs)
|
-4.24 % | 0.22 % | 3.1 % |
Strides Pharma Scien
|
Laxmi Organic Inds.
|
Wockhardt
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Customer Segment
|
Customer Segment
|
-
|
-
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|